Starbucks Corp. sell BiotechBee
Start price
22.09.22
/
60%
€86.57
Target price
31.12.24
€75.00
Performance (%)
5.46%
End price
21.12.22
€91.30
Summary
This prediction ended on 21.12.22 with a price of €91.30. With a performance of 5.46%, the SELL prediction by BiotechBee for Starbucks Corp. was trending in the wrong direction A total of €0.53 was paid as dividends for this prediction. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Starbucks Corp. | 2.064% | 2.064% | -16.670% |
iShares Core DAX® | 2.112% | -0.367% | 13.466% |
iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% |
iShares Nikkei 225® | -1.555% | -7.320% | 18.451% |
iShares S&P 500 | -0.472% | -2.078% | 27.488% |
According to BiotechBee what are the pros and cons of Starbucks Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Starbucks Corp. diskutieren
Sell mit Kursziel 75,0
In the thread Trading Starbucks Corp.
Sell beendet